Aberrant Polycystin-1 Expression Results in Modification of Activator Protein-1 Activity, whereas Wnt Signaling Remains Unaffected
Open Access
- 1 June 2004
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 279 (26), 27472-27481
- https://doi.org/10.1074/jbc.m312183200
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Synergistic cooperation between the AP‐1 and LEF‐1 transcription factors in the activation of the matrilysin promoter by the src oncogene: implications in cellular invasionThe FASEB Journal, 2003
- The β-Catenin/TCF-4 Complex Imposes a Crypt Progenitor Phenotype on Colorectal Cancer CellsCell, 2002
- The Polycystic Kidney Disease-1 Promoter Is a Target of the β-Catenin/T-cell Factor PathwayPublished by Elsevier ,2002
- AP-1 as a regulator of cell life and deathNature Cell Biology, 2002
- Polycystin-1 interacts with E-cadherin and the catenins—clues to the pathogenesis of cyst formation in ADPKD?Nephrology Dialysis Transplantation, 2000
- The N-terminal transactivation domain of ATF2 is a target for the co-operative activation of the c-jun promoter by p300 and 12S E1AOncogene, 1999
- The Polycystic Kidney Disease 1 Gene Product Mediates Protein Kinase C α-dependent and c-Jun N-terminal Kinase-dependent Activation of the Transcription Factor AP-1Journal of Biological Chemistry, 1998
- Polycystic kidney disease: The complete structure of the PKD1 gene and its proteinCell, 1995
- Autosomal dominant polycystic kidney disease: Localization of the second gene to chromosome 4q13–q23Genomics, 1993
- Identification and Partial Characterization of a Candidate Gene for X-Linked Retinopathies Using a Lateral ApproachGenomics, 1993